U.S. Gas Utilities Stock News

NYSE:OMC
NYSE:OMCMedia

Omnicom (OMC) Stock Drops As Profit Strength Meets Integration Strain

Omnicom Group walked into this earnings print with the stock quietly grinding higher in recent weeks. Today that calm broke. Shares were down about 4% intraday after the release, even as the core advertising and marketing engine delivered a sharp earnings punch. The headline this quarter is profit power, not top line drama. Non GAAP adjusted earnings per share landed at US$2.65, and core adjusted EBITA margin sat near 17.8%. That is the story the market is wrestling with: a lower share price...
NasdaqGS:ONB
NasdaqGS:ONBBanks

Should ONB’s Strong Q2 Earnings and Buyback Shift How Old National Bancorp (ONB) Investors Act?

Old National Bancorp recently reported second-quarter 2026 results, with net interest income of US$578.99 million, net income of US$253.41 million, diluted EPS of US$0.65, net charge-offs of US$32.2 million, and completion of a buyback totaling 5,148,549 shares for US$123.5 million. This combination of higher earnings, stable credit costs, and active capital return gives investors fresh information on the bank’s current profitability and balance sheet management. We’ll now assess how this...
NasdaqGS:EBC
NasdaqGS:EBCBanks

Is Eastern Bankshares (EBC) Trading At A Discount Following Lower 2026 Guidance?

Eastern Bankshares (EBC) is back in focus after issuing a slightly lower net interest income outlook for 2026, shortly after reporting second quarter results and updating investors on dividends and share repurchases. See our latest analysis for Eastern Bankshares. Eastern Bankshares shares have had a strong run, with a year to date share price return of 24.27% and a 1 year total shareholder return of 51.24% that reflects both price gains and dividends. The recent 2.17% single day decline and...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Is Stronger Rezdiffra Momentum and New Patents Altering The Investment Case For Madrigal Pharmaceuticals (MDGL)?

Madrigal Pharmaceuticals, Inc. has reported past second-quarter 2026 results showing a net loss of US$57.94 million and basic and diluted loss per share of US$1.99, widening from US$42.28 million and US$1.50 per share a year earlier, despite beating analyst expectations on earnings and revenue. Alongside this, the company highlighted growing Rezdiffra sales in MASH, new patents extending protection for resmetirom, and the start of Phase 1 testing for its oral GLP-1 candidate MGL-2086 aimed...
NYSE:BMNR
NYSE:BMNRSoftware

Bitmine Immersion Technologies (BMNR) Is Down 6.5% After Aggressive Ethereum Treasury Build-Up and Buybacks – What's Changed

In recent weeks, Bitmine Immersion Technologies accelerated its Ethereum accumulation to nearly 5% of circulating supply and stepped up a US$4.00 billion share repurchase program, while its chairman publicly emphasized Ethereum’s growing role in digital asset infrastructure and policy debates. This combination of aggressive treasury activity and vocal advocacy has positioned Bitmine as a high-profile proxy for institutional interest in Ethereum’s broader ecosystem. We’ll now examine how...
NasdaqGS:HUBG
NasdaqGS:HUBGLogistics

Hub Group (HUBG) Could Be 31% Below Fair Value Following Q2 Earnings Focus

Why the upcoming Q2 2026 earnings date matters for Hub Group Hub Group (HUBG) is set to report estimated Q2 2026 results on July 30, an event that puts fresh attention on the stock after a period of mixed operating signals. With revenue and net income figures already available for the most recent full year, and a recent share price of US$47.69, the upcoming update provides a new checkpoint on how the business is tracking. See our latest analysis for Hub Group. The upcoming Q2 update lands as...
NasdaqGS:COLB
NasdaqGS:COLBBanks

Columbia Banking System (COLB) On Strong Q2 Results And Buybacks, Is The Valuation Case Still There?

Columbia Banking System (COLB) drew fresh attention on July 23, 2026, after reporting second quarter earnings, updated net charge-offs of $30 million, and progress on a multi-hundred-million-dollar share repurchase. See our latest analysis for Columbia Banking System. At a share price of $30.78, Columbia Banking System has seen short term share price pressure, with a 7 day share price return down 5.67%, while the year to date share price return of 9.19% and 1 year total shareholder return of...
NYSE:TRGP
NYSE:TRGPOil and Gas

Targa Resources (TRGP) Following Board Appointment And Dividend Affirmation Is It Fully Valued

Targa Resources (TRGP) has drawn fresh investor attention after appointing former ConocoPhillips executive Thomas Mathiasmeier to its board and audit committee, alongside affirming a US$1.25 quarterly cash dividend. See our latest analysis for Targa Resources. The recent board appointment and dividend affirmation come after a strong run for Targa Resources, with the share price up 41.71% year to date and a 1-year total shareholder return of 61.75%, while shorter term momentum has softened...
NasdaqGS:PATK
NasdaqGS:PATKAuto Components

The Bull Case For Patrick Industries (PATK) Could Change Following Margin-Driven Q2 2026 Earnings Beat - Learn Why

Patrick Industries, Inc. has reported past second-quarter 2026 results showing sales of US$1,041.7 million, with net income rising to US$43.42 million and diluted earnings per share from continuing operations increasing to US$1.28 compared with the prior year. Despite slightly lower year-to-date sales versus the same period last year, Patrick Industries delivered higher profitability and earnings per share, underscoring the impact of margin improvement and cost discipline on its overall...
NYSE:BROS
NYSE:BROSHospitality

How Investors May Respond To Dutch Bros (BROS) Aggressive Drive-Thru Expansion And Convenience-Focused Strategy

Dutch Bros has recently continued its rapid expansion across the United States, emphasizing its drive-thru only model, acquisitions, and new shop openings to strengthen its position in the competitive coffee market. This push highlights how the brand’s convenience-focused format and distinct company culture are becoming key differentiators that draw consumer and investor attention. Next, we’ll examine how Dutch Bros’ acceleration of its drive-thru footprint could influence the company’s...
NYSE:CACI
NYSE:CACIProfessional Services

How Investors May Respond To CACI International (CACI) Winning A US Navy AI Modernization Contract

In July 2026, CACI International Inc. announced it had secured a five-year technology contract valued at up to US$113 million from the U.S. Navy’s Military Sealift Command to modernize mission-critical business applications across ashore sites and a fleet of about 140 civilian-crewed ships. By integrating artificial intelligence, advanced analytics, and intelligent automation into these systems, CACI is deepening its role in supporting the operational readiness and decision-making...
NasdaqCM:CELH
NasdaqCM:CELHBeverage

Is Celsius Holdings (CELH) Fully Valued As Earnings And Margin Pressure Cloud Its Growth Story?

Recent commentary on Celsius Holdings (CELH) has focused on a mix of softer near term earnings expectations, relatively high valuation multiples compared with peers, and pressure on margins as expenses take a larger share of revenue. See our latest analysis for Celsius Holdings. Over the past year, Celsius Holdings has experienced a sharp reset in sentiment, with the share price down 39.52% year to date and a 1 year total shareholder return decline of 37.95%. The recent 7 day share price...
NasdaqGS:VECO
NasdaqGS:VECOSemiconductor

Veeco Instruments (VECO) Stock Looks Reasonable On Earnings But Stretched On Value

After a near doubling in the last year, Veeco Instruments now sits in a zone where recent gains and the latest valuation checks are no longer pointing to an obvious bargain, even though the share price has pulled back sharply in the past month. Veeco Instruments has returned 97.7% over the past year, which puts the recent selloff into context and raises the question of how much of the good news may already be reflected in the price. Future expectations for revenue growth and cash generation...
NasdaqGS:QS
NasdaqGS:QSAuto Components

How QuantumScape’s (QS) Slower Cash Burn and Narrower Losses Could Reshape Its Licensing-Led Narrative

In the second quarter of 2026, QuantumScape Corporation reported a net loss of US$98.24 million and basic loss per share of US$0.16, both lower than the same period in 2025. Over the first half of 2026, QuantumScape cut its cumulative net loss to US$199.04 million and loss per share to US$0.32, highlighting a slower cash burn as it continues to fund solid-state battery development. Next, we will assess how this narrower quarterly net loss shapes QuantumScape’s investment narrative built...
NYSE:NMM
NYSE:NMMShipping

Navios Maritime Partners (NMM) Stock Still Looks Undervalued On Earnings Power

Navios Maritime Partners has delivered very strong long term returns over the past five years, yet the current valuation checks still suggest the stock leans cheap rather than stretched. The stock has returned about 262.5% over 5 years. This puts a lot of focus on whether today’s price still offers a margin of safety. For a shipping partnership like Navios Maritime Partners, investor expectations around shipping rates and fleet utilisation can support the current valuation. At the same time,...
NYSE:TALO
NYSE:TALOOil and Gas

Talos Energy (TALO) Eyes Earnings Growth, Is The 24% Undervaluation Justified?

Talos Energy (TALO) is drawing attention ahead of its upcoming June 2026 quarter earnings report, with expectations for significant earnings growth and a positive Earnings ESP refocusing investor interest on the stock. See our latest analysis for Talos Energy. Talos Energy's share price has moved to $14.25 after a 1-day share price return of 4.24%, with the year to date share price return of 26.67% and 1-year total shareholder return of 61.20% pointing to building momentum despite some recent...
NYSE:RNST
NYSE:RNSTBanks

Renasant (RNST) Stock Draws Attention To Margin Strength And Funding Friction

Renasant stock barely flinched after earnings, easing about 1% in Thursday trading, yet the results were anything but sleepy. The real story sits in profitability. Adjusted earnings per share for the quarter came in just under US$1, and net income held close to US$90 million, supported by a solid net interest margin and a tighter cost to income ratio than a year ago. Investors saw a quiet price move into these numbers and a much louder message in the income statement. The rest of the release...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Do Harrow’s (HROW) Retina Data Updates Quietly Redefine Its Core Growth Strategy?

Harrow recently presented three studies at the ASRS 2026 Annual Meeting highlighting interim clinical and real-world data for IHEEZO and BYOOVIZ in retinal care. The early IHEEZO data suggesting improved post-injection comfort without added antisepsis risk could meaningfully influence how ophthalmologists think about intravitreal procedures. We’ll now explore how encouraging interim IHEEZO pain and safety findings may influence Harrow’s investment narrative built around retina...
NYSE:FCPT
NYSE:FCPTSpecialized REITs

Four Corners Property Trust (FCPT) Could Be 7% Undervalued As It Expands And Extends Credit

Four Corners Property Trust (FCPT) has combined an upsized credit facility with its largest acquisition to date, the Mission Pet Health portfolio, giving investors fresh information on both balance sheet structure and portfolio mix. See our latest analysis for Four Corners Property Trust. At a share price of $26.33, Four Corners Property Trust has recorded a 13.30% year to date share price return. The 1 year total shareholder return of 8.91% sits alongside multi year total shareholder returns...
NYSE:CRI
NYSE:CRILuxury

How Carter’s Traffic-Led Growth And EPS Pressure At Carter's (CRI) Has Changed Its Investment Story

Carter's, Inc. recently indicated that its Q2 2026 results would show top-line growth supported by stronger retail traffic, new customers, and brand collaborations such as Winnie the Pooh and Umbro, even as earnings per share are expected to fall compared with the prior year. This mix of revenue momentum and profit pressure highlights how Carter's is leaning on direct-to-consumer strength and pricing and productivity initiatives to offset tariffs, inflation, and cautious discretionary...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

Nvidia And 2 More Crypto Stocks Building AI Infrastructure

Global markets are wrestling with mixed inflation signals, shifting rate expectations and higher energy costs. That backdrop keeps investors focused on assets that can potentially benefit as digital infrastructure and new transaction systems evolve. The Top Cryptocurrency and Blockchain Stocks screener filters this wide universe into a more manageable starting list based on clear, transparent criteria. That helps you focus on businesses linked to crypto and blockchain themes without having to...
NYSE:MUR
NYSE:MUROil and Gas

Murphy Oil’s Earnings Beat Streak Raises Fresh Questions About MUR’s Long‑Term Profitability Narrative

Murphy Oil previously announced it was expected to report higher year-over-year earnings and revenues for the June 2026 quarter, with the earnings release scheduled for August 5 and analyst models indicating a likely earnings beat based on an Earnings ESP of 0.25% and a Zacks Rank of 3. An interesting angle for investors is Murphy Oil’s consistent record of surpassing consensus EPS estimates in each of the last four quarters, which has fueled confidence in the company’s upcoming results...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

The Bull Case For Liquidia (LQDA) Could Change Following Buckley’s Yutrepia Court-Ruling Confidence - Learn Why

In recent weeks, Buckley Capital Advisors highlighted Liquidia Corporation in its Q2 2026 investor letter, crediting the company as a major contributor to portfolio gains and expressing confidence in a favorable judicial ruling on Liquidia’s ability to sell Yutrepia for PH-ILD. This external investor commentary has sharpened attention on Liquidia’s legal outcomes and potential buyout interest, adding an additional layer of focus to the company’s existing product, earnings and pipeline...
NasdaqGM:BCAX
NasdaqGM:BCAXBiotechs

Will New Oncology Veterans on Bicara Therapeutics' (BCAX) Board Reshape Its Late-Stage Strategy?

Bicara Therapeutics recently appointed Jeremy Bender, Ph.D., MBA, former CEO of Day One Biopharmaceuticals, and ex-Genentech oncology leader Christy Oliger to its Board of Directors, while Kiran Mazumdar-Shaw retired from the board. The additions bring deep experience in oncology drug launches, large-scale portfolio management and major biotech M&A, potentially influencing how Bicara approaches late-stage development and commercialization decisions. Next, we’ll examine how adding experienced...